• 1. H-phosphonate-mediated sulfonylation of heteroaromatic N-oxides: a mild and metal-free one-pot synthesis of 2-sulfonyl quinolines/pyridines
  Kai Sun,Xiao-Lan Chen,Xu Li,Ling-Bo Qu,Wen-Zhu Bi,Xi Chen,Hui-Li Ma,Song-Tao Zhang,Bo-Wen Han,Yu-Fen Zhao,Chao-Jun Li Chem. Commun. 2015 51 12111
• 2. 102. Kinetic studies in the phosphinyl chloride and phosphorochloridate series. Part II. Reaction of diisopropyl phosphorochloridate with anionic reagents
  I. Dostrovsky,M. Halmann J. Chem. Soc. 1953 508
• 3. 103. Kinetic studies in the phosphinyl chloride and phosphorochloridate series. Part III. Reactions with amines
  I. Dostrovsky,M. Halmann J. Chem. Soc. 1953 511
• 4. 101. Kinetic studies in the phosphinyl chloride and phosphorochloridate series. Part I. Solvolytic reactions
  I. Dostrovsky,M. Halmann J. Chem. Soc. 1953 502
• 5. 104. Kinetic studies in the phosphinyl chloride and phosphorochloridate series. Part IV. General discussion
  I. Dostrovsky,M. Halmann J. Chem. Soc. 1953 516

Recent Advances in the Application of Bis(propan-2-yl) Phosphorochloridate (CAS 2574-25-6) in Chemical Biology and Pharmaceutical Research

Bis(propan-2-yl) phosphorochloridate (CAS 2574-25-6) is a key intermediate in the synthesis of organophosphorus compounds, which have broad applications in chemical biology and pharmaceutical research. Recent studies have highlighted its utility in the development of prodrugs, enzyme inhibitors, and novel therapeutic agents. This research brief synthesizes the latest findings on the compound's reactivity, synthetic applications, and potential therapeutic implications, providing a comprehensive overview for researchers in the field.

One of the most significant advancements involves the use of bis(propan-2-yl) phosphorochloridate as a phosphorylating agent in the synthesis of nucleotide analogs. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in the preparation of phosphoramidate prodrugs, which exhibit enhanced bioavailability and targeted delivery. The study reported a 40% increase in prodrug stability compared to traditional phosphorylation methods, underscoring the compound's potential in optimizing drug formulations.

In addition to its role in prodrug development, bis(propan-2-yl) phosphorochloridate has been investigated for its application in enzyme inhibition. Research published in ACS Chemical Biology in early 2024 revealed its utility in the selective inhibition of serine hydrolases, a class of enzymes implicated in various disease pathways. The study utilized X-ray crystallography to elucidate the binding mechanism, showing that the compound forms a stable covalent adduct with the active site serine residue, thereby providing a template for the design of next-generation inhibitors.

Another emerging area of research focuses on the compound's use in the synthesis of phosphorothioate oligonucleotides, which are critical components in mRNA therapeutics and gene editing technologies. A recent preprint on bioRxiv detailed a novel, high-yield synthetic route employing bis(propan-2-yl) phosphorochloridate, achieving a 90% purity rate while reducing byproduct formation. This advancement addresses a key challenge in oligonucleotide manufacturing, paving the way for more efficient production processes.

Safety and handling considerations for bis(propan-2-yl) phosphorochloridate have also been a focus of recent investigations. A 2023 regulatory review in Chemical Research in Toxicology highlighted the compound's acute toxicity profile and recommended stringent handling protocols, including the use of inert atmospheres and personal protective equipment. These findings are particularly relevant for industrial-scale applications, where safety remains a paramount concern.

Looking ahead, the versatility of bis(propan-2-yl) phosphorochloridate continues to inspire innovative applications. Current preclinical studies are exploring its use in the development of phosphonate-based antivirals, with preliminary data showing promising activity against RNA viruses. As research progresses, this compound is poised to play an increasingly important role in addressing unmet medical needs and advancing pharmaceutical innovation.

• 2510-89-6(Dipropyl chlorophosphate)
• 89104-48-3(1,3,2-Dioxaphospholane,2-chloro-4,5-dimethyl-, 2-oxide, [4R-(2a,4a,5b)]- (9CI))
• 13674-83-4(1-Chloro-2-propanol Phosphorochloridate)
• 872-99-1(2-chloro-1,3,2lambda5-dioxaphosphinan-2-one)
• 112966-13-9(Anderson-Shapiro reagent)
• 6609-64-9(2-Chloro-1,3,2-dioxaphospholane-2-oxide)
• 819-43-2(Di-n-Butyl Phosphorochloridate)
• 56119-60-9(tert-Butyl Phosphorochloridate)
• 17158-87-1(bis(2-methylpropyl) phosphorochloridate)
• 10140-90-6(1,3,2-Dioxaphosphorinane,2-chloro-4,6-dimethyl-, 2-oxide)